血管舒缩症状与绝经后女性骨折风险及骨密度的关联:观察性研究的系统综述与Meta分析
该系统综述与Meta分析纳入20项观察性研究(定量分析12项,n=49,659),评估血管舒缩症状(VMS)与骨折风险及骨密度的关联。VMS与低骨密度相关(OR 1.54,95%CI 1.42-1.67),但未发现与骨折风险存在差异(OR 1.04,95%CI 0.93-1.16)。
要点
- VMS与低骨密度相关(OR 1.54,95%CI 1.42-1.67,I²=0%)。
- VMS与骨折风险无显著差异(OR 1.04,95%CI 0.93-1.16,I²=16%)。
- 腰椎骨密度与VMS相关(MD -0.019 g/cm²,95%CI -0.03至-0.008)。
核心结论
- VMS的存在与绝经后女性低骨密度相关,但似乎不增加骨折风险。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Scopus和Cochrane数据库至2023年8月31日,纳入观察性研究。
- 定性分析纳入20项研究,定量分析纳入12项研究(n=49,659)。
- 评估结局包括骨折、低骨密度(骨质疏松/骨量减少)及腰椎和股骨颈骨密度平均变化。
- 采用OR和MD及95%CI呈现结果,I²指数量化异质性。
主要发现
- VMS与骨折风险无差异(n=5,OR 1.04,95%CI 0.93-1.16,I²=16%)。
- VMS与低骨密度相关(n=5,OR 1.54,95%CI 1.42-1.67,I²=0%)。
- 腰椎骨密度与VMS相关(MD -0.019 g/cm²,95%CI -0.03至-0.008,I²=85.2%)。
- 股骨颈骨密度与VMS无显著关联(MD -0.010 g/cm²,95%CI -0.021至0.001,I²=78.2%)。
- 结果独立于VMS严重程度、年龄和研究设计;排除使用绝经激素治疗的研究后,与骨密度的关联仍显著。
关键数值与推荐
- VMS与低骨密度关联的OR为1.54(95%CI 1.42-1.67,I²=0%)。
- VMS与骨折风险关联的OR为1.04(95%CI 0.93-1.16,I²=16%)。
- 腰椎骨密度平均差为-0.019 g/cm²(95%CI -0.03至-0.008,I²=85.2%)。
- 股骨颈骨密度平均差为-0.010 g/cm²(95%CI -0.021至0.001,I²=78.2%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: Vasomotor symptoms (VMS) adversely affect postmenopausal quality of life. However, their association with bone health has not been elucidated. This study aimed to systematically review and meta-analyze the evidence regarding the association of VMS with fracture risk and bone mineral density (BMD) in peri- and postmenopausal women. METHODS: A literature search was conducted in PubMed, Scopus and Cochrane databases until 31 August 2023. Fracture, low BMD (osteoporosis/osteopenia) and mean change in lumbar spine (LS) and femoral neck (FN) BMD were assessed. The results are presented as odds ratio (OR) and mean difference (MD), respectively, with a 95% confidence interval (95% CI). The I2 index quantified heterogeneity. RESULTS: Twenty studies were included in the qualitative and 12 in the quantitative analysis (n=49,659). No difference in fractures between women with and without VMS was found (n=5, OR 1.04, 95% CI 0.93-1.16, I2 16%). However, VMS were associated with low BMD (n=5, OR 1.54, 95% CI 1.42-1.67, I2 0%). This difference was evident for LS (MD -0.019 g/cm2, 95% CI -0.03 to -0.008, I2 85.2%), but not for FN BMD (MD -0.010 g/cm2, 95% CI -0.021 to 0.001, I2 78.2%). These results were independent of VMS severity, age and study design. When the analysis was confined to studies that excluded menopausal hormone therapy use, the association with BMD remained significant. CONCLUSIONS: The presence of VMS is associated with low BMD in postmenopausal women, although it does not seem to increase fracture risk.
引用
- Anagnostis P, Lallas K, Pappa A, et al. The association of vasomotor symptoms with fracture risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis of observational studies. Osteoporos Int. 2024. PMID: 38563960. doi:10.1007/s00198-024-07075-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。